Development of a Bayesian Belief Network Model for Personalized Prognostic Risk Assessment in Colon Carcinomatosis
暂无分享,去创建一个
[1] K. Westbrook,et al. Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors , 1989, Cancer.
[2] P. Sugarbaker,et al. Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management. , 1994, Acta chirurgica Belgica.
[3] W. Isaacs,et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. , 1999, Cancer research.
[4] J. Faure,et al. Peritoneal carcinomatosis from non‐gynecologic malignancies , 2000, Cancer.
[5] A. Norman,et al. A clinical nomogram for predicting long-term survival in advanced colorectal cancer. , 2000, European journal of cancer.
[6] L. Kiemeney,et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. , 2002, Cancer research.
[7] D. Jayne,et al. Peritoneal carcinomatosis from colorectal cancer , 2002, The British journal of surgery.
[8] L. Kiemeney,et al. DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer , 2003 .
[9] H. van Tinteren,et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[11] F. Kwiatkowski,et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Tomoyuki Kato,et al. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer , 2004, The British journal of surgery.
[13] M. West,et al. Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers , 2005, Clinical Cancer Research.
[14] Yuka Igari,et al. Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a bayesian approach , 2005, Breast cancer.
[15] Lurdes Y. T. Inoue,et al. Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. , 2006, Journal of the National Cancer Institute. Monographs.
[16] J. Esquivel,et al. Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination , 2008, Journal of surgical oncology.
[17] E. Levine,et al. Peritoneal Surface Disease from Colorectal Cancer: Comparison with the Hepatic Metastases Surgical Paradigm in Optimally Resected Patients , 2008, Annals of Surgical Oncology.
[18] Mithat Gonen,et al. Individualized prediction of colon cancer recurrence using a nomogram. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] M. Kattan,et al. A Nomogram for Predicting Disease-specific Survival After Hepatic Resection for Metastatic Colorectal Cancer , 2008, Annals of surgery.